Looking to publish in Artificial Cells Nanomedicine and Biotechnology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginArtificial Cells, Nanomedicine, and Biotechnology is an interdisciplinary journal publishing high-quality open access research at the convergence of artificial cells, nanomedicine, and health-related biotechnology. The journal emphasizes original research demonstrating game-changing and disruptive technologies, new concepts, and innovative experimental approaches, and also publishes translational work such as clinical implementation. It accepts original papers, reviews, method articles, data notes, registered reports, and editorials by invitation only, and operates a single-anonymized peer review policy.
Looking to publish in Artificial Cells Nanomedicine and Biotechnology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Artificial Cells Nanomedicine and Biotechnology accepts the following article types. Click on an article type to view submission instructions.
Original Paper
Review
Registered Report
Recent Publications
Network pharmacology, and molecular docking studies for two flavonoid compounds isolated from Dodonaea viscosa towards SARS-CoV-2 infection and loaded in lipid nanoparticles
Marzough Aziz Albalawi, Sameera Al-Ghamdi, Mahmoud Fahmi Elsebai, Marwa Anwar Wagdi, Saadiya EL-Nahas, Mohammad Y. Alfaifi, Banan Al-Shagour, Fatma Alzahraa Mokhtar
Artificial intelligence-driven design of next-generation nanomedicine: transforming precision healthcare
R. D. K. Misra
Recent advances of CRISPR-based gene editing technologies and delivery strategies
Fanyu Xue, Zixuan Xin, Gaojie Wang, Jiayin Xing, Hengxin Han, Xiangxiang Zhao, Ningning Song
Retraction Statement: Long non-coding RNA LINC00858 promotes cells proliferation, migration and invasion by acting as a ceRNA of miR-22-3p in colorectal cancer
-
Retraction Statement: Overexpression of the long non-coding RNA Oprm1 alleviates apoptosis from cerebral ischemia-reperfusion injury through the Oprm1/miR-155/GATA3 axis
-
Frequently asked questions
How long does it take to publish?
Average (median) days are tracked for submission to first decision, submission to first post-review decision, and acceptance to online publication.
Reformat to Artificial Cells Nanomedicine and Biotechnology using Livewrite PremiumWhat are the publication costs?
Open access publishing costs may be covered by a Taylor & Francis institutional open access agreement; no journal-specific APC is stated.
Reformat to Artificial Cells Nanomedicine and Biotechnology using Livewrite Premium